Shannon Stockton, MD, studies the molecular pathogenesis of myelodysplastic syndromes (MDS). She is using electronic health record data to determine associations between MDS pathogenesis and prognosis based on comorbidities, somatic clonal changes, as well as inherited single nucleotide polymorphisms (SNPs).
Originally from Orlando, Florida, Shannon began research as a high school student at MD Anderson Cancer Center Orlando (now UF Health Cancer Center Orlando) in 2008 studying the combined effects of an NSAID, radiation therapy, and cerium oxide nanoparticles in head and neck cancer. She continued research with Dr. Robert Hromas at the University of Florida, completing her Honors thesis research on mismatch repair defects and microsatellite instability in colorectal cancer. Her growing interest in hematopoieitic malignancies led her to the study of the clinical correlations with underlying gene mutations with Dr. Chris Cogle which has prepared her well in her current project.